What You Should Know:
– Trinity Guardion, a leader in hospital bed hygiene solutions, has successfully raised $6 million, including $3.5 million in a Series B funding round.
– This investment will accelerate the production and commercialization of the innovative Soteria® Bed Barrier System.
Trinity Guardion’s Soteria Bed Barrier: Advancing Infection Control in Hospital Environments
Founded in 2010 and headquartered in Batesville, Indiana, Trinity Guardion specializes in FDA-cleared, reusable hospital bed barriers aimed at minimizing infection risk in acute care, neonatal, and long-term care settings. Their flagship product, the Soteria Bed Barrier, gained FDA clearance in late 2022, serving as a robust solution to prevent mattress soiling, curb infection spread, and extend mattress life.
The Soteria Bed Barrier offers crucial benefits:
– Bed and Patient Protection: Hospital mattresses are vulnerable to contamination from bodily fluids and compromised skin. The Soteria Bed Barrier fully envelops both mattress and bed frame, preventing fluid penetration and simplifying cleaning protocols. This protective feature not only ensures a cleaner surface but also significantly reduces the time needed for maintenance.
– Infection Prevention: Studies consistently highlight the infection risk posed by contaminated hospital mattresses. Notably, a 2023 study from Emory University found that contaminated beds can transmit infections to new patients up to 90 days post-use. By integrating an advanced laundry system that removes 99.9999% of pathogens, the Soteria Bed Barrier contributes to a substantial reduction—50%—in hospital-onset C. diff infections.
The Soteria® Ecosystem further enhances efficiency, utilizing RFID technology and a cloud-based platform to streamline bed barrier management. This system enables healthcare facilities to monitor barrier availability and cleanliness, optimizing their readiness for patient use. Trinity Guardion’s recent product innovation, the Soteria® Neonatal Mattress Barrier, provides high-level protection tailored to neonatal care, simplifying the sanitization process for delicate patients.
Investor Rich Grant emphasizes the product’s value, noting, “Hospital beds and mattresses can harbor infections. The Trinity Guardion solution ensures a cleaner surface and reduces the prevalence of hospital-acquired infections.”
Trinity Guardion’s recent investment round, led by Queen City Angels with participation from Tamiami Angel Fund, Market Street Ventures, and RKCA, underscores market confidence in their products. Legal guidance for the investment round was provided by Keating, Muething & Klekamp PLL.
Bruce Rippe, Founder and CEO of Trinity Guardion, said, “This investment will help us expand our reach and strengthen our partnerships with hospitals focused on patient safety.”
